Navigation Links
Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence

CHAPEL HILL, N.C., May 30 /PRNewswire/ -- Given the increasing challenges to patent protection and new product approvals, pharmaceutical companies continue to seek external opportunities to grow their pipelines. With the increasing merger and acquisition activity, industry experts have found the importance of proper integration of assets to be key in obtaining value as described in the newly published study, "M&A Integration Excellence: What Bio- Pharma Companies Need to Know." Best Practices, LLC recently completed this new study utilizing benchmark metrics and executive insights to assess current trends and future directions of bio-pharmaceutical M&A activity and keys to obtaining asset value through optimal integration.

In a benchmarking study that included such influential companies as Pfizer, Lilly, Johnson & Johnson and Abbott, it was found that managing cultural issues was both highly important and extremely difficult to optimize. Integration experts discussed methods for managing such issues through proper planning and execution as described in the study report.

For a complimentary summary of the full report "M&A Integration Excellence: What Bio-Pharma Companies Need to Know," click on the following link

Other key topic areas in the research include:

- Structure for Integration

- Pre-Integration Planning Activities

- Integration Risk Management

- Integration Functional Excellence

- Communications Excellence

- Understanding & Managing Cultural Issues

- Post-Deal Closure Integration Activities

- Trends in M&A Integration

Among the key topics gathered in this report are:

- Industry Integration Functional Efficacy

- Efficacy of Integration Structural Approaches

- Integration Planning Initiation

- Pre-Integration Planning Activity Efficacy

- Integration Planning Activity Resource Intensity

- Integration Risk-Assessment Factor Importance

- Integration Approach Assessments

- Post-Deal Closure Integration Ownership

- Time to Integration Stability By Organization Size

- Performance Indicators for Integration Performance Measurement

For more information on this report, contact Robert Naylor at or (919) 767-9244. To access the full report or download a complimentary copy of the report summary, go to


Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more than 15 years, our highly credentialed research staff has conducted primary research exclusively for our Fortune 500 client base.

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities
2. Huifeng Bio-Pharmaceutical (HFGB) to Release First Quarter 2008 Earnings Results on May 15, 2008
3. Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou
4. Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.
5. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
6. Skystar Bio-Pharmaceutical Raises 2007 Revenue Guidance to $15.8 Million
7. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
8. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
9. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
10. Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry
11. Record Venture Capital and Heated Deal Environment Propel Global Biotechnology Industry Forward in 2007
Post Your Comments:
(Date:11/25/2015)... ... 25, 2015 , ... Jessica Richman and Zachary Apte, founders ... initial angel funding process. Now, they are paying it forward to other microbiome ... investments in the microbiome space. In this, they join other successful entrepreneurs-turned-angels ...
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
(Date:11/24/2015)... AVIV, Israel , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: ... held on December 29, 2015 at 11:00 a.m. Israel ... Co., Electra Tower, 98 Yigal Allon Street, 36 th Floor, ... election of Eric Paneth and Izhak Tamir to ... and Rami Skaliter as external directors; , approval of an amendment ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
Breaking Biology News(10 mins):